Low clinical penetrance in causal mutation carriers for cardiac channelopathies;Baja penetrancia clínica en sujetos portadores de mutación patogénica para las canalopatías cardiacas

Revista Espanola de Cardiologia

Volumn 66, Issue 4, 2013, Pages 275-281

  Jiménez Jáimez, Juan ^a   Álvarez, Miguel ^a   Algarra, María ^a   Ruíz, Rosa MacÍas ^a   Peñas, Rocío ^a   Valverde, Francisca ^a   Tortajada, Gustavo ^a   Lorente, Jose Antonio ^b   Melgares, Rafael ^a   Tercedor, Luis ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

Author keywords

Brugada syndrome; Channelopathies; Genetic mutation; Idiopathic ventricular fibrillation; Long QT syndrome; Sudden cardiac death

Indexed keywords

ADRENALIN; FLECAINIDE;

ARTICLE; BRUGADA SYNDROME; ELECTROCARDIOGRAPHY; GENE MUTATION; GENETIC PREDISPOSITION; HETEROZYGOTE; HUMAN; LONG QT SYNDROME; PATHOGENICITY; PHENOTYPE; SENSITIVITY ANALYSIS; SHWARTZMAN PHENOMENON; ADULT; CHANNELOPATHY; COMPLICATION; FEMALE; GENETICS; HEART DISEASE; MALE; MIDDLE AGED; MUTATION; PATHOPHYSIOLOGY; PENETRANCE; YOUNG ADULT;

ADULT; BRUGADA SYNDROME; CHANNELOPATHIES; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; MUTATION; PENETRANCE; YOUNG ADULT;

EID: 84884213829     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.09.011     Document Type: Article

References (30)

1. E.R. Behr, A. Casey, M. Sheppard, M. Wright, T.J. Bowker, and M.J. Davies Sudden arrhythmic death syndrome: a national survey of sudden unexplained cardiac death Heart 93 2007 601 605
2. E. Marban Cardiac channelopathies Nature 415 2002 213 218
3. S.G. Priori, C. Napolitano, and P.J. Schwartz Low penetrance in the long-QT syndrome clinical impact Circulation 99 1999 529 533
4. E. Behr, D.A. Wood, M. Wright, P. Syrris, M.N. Sheppard, and A. Casey Cardiological assessment of first-degree relatives in sudden arrhythmic death syndrome Lancet 362 2003 1457 1459
5. E.R. Behr, C. Dalageorgou, M. Christiansen, P. Syrris, S. Hughes, and M.T. Tome Esteban Sudden arrhythmic death syndrome: familial evaluation identifies inheritable heart disease in the majority of families Eur Heart J 29 2008 1670 1680
6. H.L. Tan, N. Hofman, I.M. Van Langen, A.C. Van der Wal, and A.A. Wilde Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives Circulation 112 2005 207 213
7. P.J. Schwartz, A.J. Moss, G.M. Vincent, and R.S. Crampton Diagnostic criteria for the long QT syndrome. An update Circulation 88 1993 782 784
8. C. Antzelevitch, P. Brugada, M. Borggrefe, J. Brugada, R. Brugada, and D. Corrado Brugada syndrome: report of thesecond consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association Circulation 111 2005 659 670
9. A.D. Krahn, J.S. Healey, V. Chauhan, D.H. Birnie, C.S. Simpson, and J. Champagne Systematic assessment of patients with unexplained cardiac arrest: Cardiac Arrest Survivors With Preserved Ejection Fraction Registry (CASPER) Circulation 120 2009 278 285
10. J. Jiménez-Jáimez, L. Tercedor-Sánchez, M. Álvarez-López, E. Martínez-Espín, R. Sebastián Galdeano, and I. Almansa-Valencia Estudio genético en el síndrome de QT largo en nuestro medio Rev Esp Cardiol 64 2011 71 74
11. G. Lande, F. Kyndt, I. Baró, D. Chabannes, P. Boisseau, and J.C. Pony Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype Eur Heart J 22 2001 410 422
12. A.D. Krahn, M. Gollob, R. Yee, L.J. Gula, A.C. Skanes, and B.D. Walker Diagnosis of unexplained cardiac arrest: role of adrenaline and procainamide infusion Circulation 112 2005 2228 2234
13. J.M. Fish, and C. Antzelevitch Role of sodium and calcium channel block in unmasking the Brugada syndrome Heart Rhythm 1 2004 210 217
14. S. Kapa, D.J. Tester, B.A. Salisbury, C. Harris-Kerr, M.S. Pungliya, and M. Alders Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants Circulation 120 2009 1752 1760
15. H. Bazett An analysis of the time-relations of electrocardiograms Heart 7 1920 353 370
16. W. Shimizu, T. Noda, H. Takaki, N. Nagaya, K. Satomi, and T. Kurita Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome Heart Rhythm 1 2004 276 283
17. I. Amorós, J. Jiménez-Jáimez, L. Tercedor, A. Barana, R. Gómez, and M.G. De la Fuente Functional effects of a missense mutation in HERG associated with type 2 long QT syndrome Heart Rhythm 8 2011 463 470
18. G.M. Vincent, K.W. Timothy, M. Leppert, and M.T. Keating The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome N Engl J Med 327 1992 846 852
19. S. Richter, A. Sarkozy, G. Paparella, S. Henkens, T. Boussy, and G.B. Chierchia Number of electrocardiogram leads displaying the diagnostic coved-type pattern in Brugada syndrome: a diagnostic consensus criterion to be revised Eur Heart J 31 2010 1357 1364
20. D.M. Roden, and T. Yang Protecting the heart against arrhythmias: potassium current physiology and repolarization Circulation 112 2005 1376 1378
21. I. Goldenberg, S. Horr, A.J. Moss, C.M. Lopes, A. Barsheshet, and S. McNitt Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals J Am Coll Cardiol 57 2011 51 59
22. A. Varró, and J.G. Papp Low penetrance, subclinical congenital LQTS: concealed LQTS or silent LQTS? Cardiovasc Res 70 2006 404 406
23. S.G. Priori, P.J. Schwartz, C. Napolitano, R. Bloise, E. Ronchetti, and M. Grillo Risk stratification in the long-QT syndrome N Engl J Med 348 2003 1866 1874
24. V. Probst, C. Veltmann, L. Eckardt, P.G. Meregalli, F. Gaita, and H.L. Tan Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry Circulation 121 2010 635 643
25. D. Darbar Is it time to develop a "pathogenicity" score to distinguish long QT syndrome causing mutations from "background" genetic noise? Heart Rhythm 6 2009 1304 1305
26. D.J. Tester, M.L. Will, C.M. Haglund, and M.J. Ackerman Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing Heart Rhythm 2 2005 507 517
27. I. Splawski, J. Shen, K.W. Timothy, M.H. Lehmann, S. Priori, and J.L. Robinson Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Circulation 102 2000 1178 1185
28. W. Shimizu, T. Noda, H. Takaki, T. Kurita, N. Nagaya, and K. Satomi Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long QT syndrome J Am Coll Cardiol 41 2003 633 642
29. H. Vyas, J. Hejlik, and M.J. Ackerman Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response Circulation 113 2006 1385 1392
30. M. Abello, J.L. Merino, R. Peinado, and M. Gnoatto Negative flecainide test in Brugada syndrome patients with previous positive response Europace 8 2006 899 900